Bio-Rad Laboratories, Inc. - Anti-idiotypic Antibodies
Manufactured by Bio-Rad Laboratories, Inc.
Bio-Rad has developed highly specific, high affinity anti-biotherapeutic antibodies to support preclinical research,...
Bio-Rad has developed highly specific, high affinity anti-biotherapeutic antibodies to support preclinical research, clinical trials and patient monitoring for innovator and biosimilar products.
We use the HuCAL® recombinant monoclonal antibody library and an improved method of antibody phage display to generate these fully human antibodies in Fab and full immunoglobulin formats.
Select antibodies to your target from our industry-leading range of premade antibodies against marketed blockbuster monoclonal antibody drugs, or commission a custom made antibody against your proprietary biotherapeutic lead candidate.
We have a 100% success rate generating neutralizing anti-idiotypic antibodies (type 1) and also use guided selection strategies to develop non-neutralizing anti-idiotypic (type 2) and drug-target complex (type 3) antibodies.
We use the HuCAL® recombinant monoclonal antibody library and an improved method of antibody phage display to generate these fully human antibodies in Fab and full immunoglobulin formats.
Select antibodies to your target from our industry-leading range of premade antibodies against marketed blockbuster monoclonal antibody drugs, or commission a custom made antibody against your proprietary biotherapeutic lead candidate.
We have a 100% success rate generating neutralizing anti-idiotypic antibodies (type 1) and also use guided selection strategies to develop non-neutralizing anti-idiotypic (type 2) and drug-target complex (type 3) antibodies.
Active Questions & AnswersAsk a Question
There are no current Discussions
Antibodies Service ProvidersView All (3)
Documents & Manuals
There are no Documents or Manuals available.
Features of Anti-idiotypic Antibodies
Special features of our ready-made antibodies and our custom service include:
High specificity and sensitivity for optimal PK assay development Specialized antibodies targeting a complex of the drug and target Fully human immunoglobulins as controls for ADA assays Security, consistency and an unlimited supply throughout preclinical and clinical studies
General Specifications
There are no General Specifications available.